239 results on '"Poddubnyy, D"'
Search Results
2. POS0029 ENHANCING THE DIAGNOSTIC ACCURACY AND AVOIDING OVERDIAGNOSIS IN AXIAL SPONDYLOARTHRITIS THROUGH CENTRAL EVALUATION OF IMAGING: IMPROVE-axSpA, A NATIONWIDE TELEMEDICINE PROJECT
3. POS0249 ASSOCIATIONS BETWEEN CLINICAL CHARACTERISTICS AND SCREENING MRI FINDINGS: EXPLORATORY ANALYSIS OF THE ONGOING PHASE 4, MULTICENTER, RANDOMIZED, CONTROLLED STAR STUDY OF BIOLOGIC-NAÏVE PATIENTS WITH PsA WITH MRI-CONFIRMED AXIAL INVOLVEMENT
4. POS0508 WHAT FACTORS ARE ASSOCIATED WITH PAIN INTENSITY IN AXIAL SPONDYLOARTHRITIS? RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
5. POS0227 CLUSTER ANALYSIS IDENTIFIES PARTICULAR PAIN PROFILES IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
6. AB0942 NOCICEPTIVE, NEUROPATHIC, AND NOCIPLASTIC COMPONENTS OF PAIN IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: BASELINE RESULTS FROM AN ONGOING OBSERVATIONAL STUDY
7. LBA0003 MINIMAL SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS OVER 2 YEARS OF BIMEKIZUMAB TREATMENT: RESULTS FROM A PHASE 3 OPEN-LABEL EXTENSION STUDY
8. POS0050 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 SELECT-AXIS 2 STUDY
9. OP0284 FREQUENCY AND FACTORS ASSOCIATED WITH THE PRESENCE OF ACTIVE INFLAMMATORY AND STRUCTURAL CHANGES IN THE MRI OF SACROILIAC JOINTS: RESULTS FROM A POPULATION-BASED STUDY
10. POS0194 FACTORS ASSOCIATED WITH RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING IL-17A INHIBITOR OR TNF INHIBITOR THERAPY: A POST-HOC ANALYSIS OF THE SURPASS STUDY
11. POS0215 LONG-TERM SAFETY AND EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 5-YEAR RESULTS FROM A PHASE 2B STUDY AND ITS OPEN-LABEL EXTENSION
12. POS0497 EFFECT OF DEPRESSIVE SYMPTOMS ON REMISSION IN axSpA PATIENTS: AN ANALYSIS FROM THE RABBIT-SpA COHORT
13. AB0881 LONG-TERM SAFETY AND TOLERABILITY OF BIMEKIZUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM POOLED PHASE 2B/3 STUDIES
14. POS0058 IMPACT OF BIMEKIZUMAB ON MRI INFLAMMATORY AND STRUCTURAL LESIONS IN THE SACROILIAC JOINTS OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS AND POST HOC ANALYSES FROM THE BE MOBILE 1 AND 2 PHASE 3 STUDIES
15. AB0945 THE IMPACT OF AXIAL SPONDYLOARTHRITIS ON PATIENTS’ SEXUAL LIFE. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
16. LBA0006 SECUKINUMAB VERSUS STANDARD-OF-CARE IN AXIAL SPONDYLOARTHRITIS: A RANDOMIZED CONTROLLED OPEN-LABEL TRIAL FOR TREAT-TO-TARGET OUTCOMES (ASCALATE)
17. POS0291 BIOMARKER OF DISTURBED GUT BARRIER UNDER THERAPY WITH TNF INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
18. POS0507 FACTORS ASSOCIATED WITH POOR MENTAL HEALTH IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
19. Résolution des enthésites et des arthrites périphériques avec le bimékizumab chez les patients atteints de spondyloarthrite axiale : résultats à la semaine 52 des études de phase III BE MOBILE 1 et BE MOBILE 2
20. Tolérance et efficacité à long terme du bimékizumab chez les patients atteints de spondylarthrite ankylosante active : résultats à 5 ans d’une étude de phase IIb et de son extension en ouvert
21. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : analyse en sous-groupes avec sur le statut syndesmophytes et protéine C-réactive à l’inclusion
22. Le bimékizumab réduit les lésions inflammatoires à l’IRM chez les patients atteints de spondyloarthrite axiale : résultats à la semaine 52 des études de phase III BE MOBILE 1 et 2
23. Tolérance à long terme du bimékizumab chez les patients atteints de spondyloarthrite axiale (axSpA) et de rhumatisme psoriasique (RhPso) : résultats groupés des études de phase IIb/III
24. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : étude randomisée de phase 3b
25. POS0246 BIMEKIZUMAB REDUCED MRI INFLAMMATORY LESIONS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: WEEK 52 RESULTS FROM THE BE MOBILE 1 AND BE MOBILE 2 PHASE 3 STUDIES
26. POS0247 RESOLUTION OF ENTHESITIS AND PERIPHERAL ARTHRITIS WITH BIMEKIZUMAB IN PATIENTS WITH AXIAL SPODYLOARTHRITIS: WEEK 52 RESULTS FROM THE BE MOBILE 1 AND BE MOBILE 2 PHASE 3 STUDIES
27. POS0039 A MULTIOMICS PLASMA ANALYSIS REVEALS NEW PATHWAYS CENTRAL IN DRIVING INFLAMMATION IN SPONDYLOARTHRITIS
28. AB1010 WHICH FACTORS ARE ASSOCIATED WITH CLINICALLY HIGH DISEASE ACTIVITY IN AXIAL SPONDYLOARTHRITIS? RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
29. POS0299 NEUROPATHIC AND NEUROPLASTIC PAIN COMPONENTS DETERMINE THE PRESENCE OF RESIDUAL SYMPTOMS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
30. AB0093 COMPLEMENT IN THE DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS (AXSPA). INVESTIGATIONS IN A CROSS-SECTIONAL COHORT (OPTIREF) OF PATIENTS SUSPECTED OF AXIAL SPONDYLOARTHRITIS
31. OP0187 REGIONAL DIFFERENCES IN CLINICAL PHENOTYPE OF AXIAL SPONDYLOARTHRITIS. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
32. POS0921 INFLUENCE OF HLA-B27 STATUS ON MR IMAGING FINDINGS IN PATIENTS WITH LOW BACK PAIN
33. POS0878 SCREENING FOR THE EARLY IDENTIFICATION OF PSORIATIC ARTHRITIS WITH AXIAL INVOLVEMENT (AXPSA) IN A COHORT OF ITALIAN PATIENTS AFFECTED BY PSORIASIS: RESULTS OF A DERMO-RHEUMATOLOGIC CROSS-SECTIONAL STUDY (ATTRACT)
34. OP0057 FACTORS ASSOCIATED WITH ACHIEVING REMISSION IN PATIENTS WITH EARLY PERIPHERAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT (GESPIC)
35. POS0689 DIAGNOSTIC DELAY IN PATIENTS INCLUDED IN THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRTIS: ASSOCIATIONS WITH GEOGRAPHIC, SOCIO-DEMOGRAPHIC AND DISEASE-RELATED FACTORS
36. AB0987 FEMALES WITH AXIAL SPONDYLOARTHRITIS REPORT HIGHER BURDEN OF DISEASE AND WORSE PATIENT-REPORTED OUTCOMES. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
37. POS0250 PLACEBO-CONTROLLED EFFICACY AND SAFETY OF UPADACITINIB THROUGH ONE YEAR IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
38. POS0429 THE COMPLEMENT SYSTEM AND RESPONSE TO TNF INHIBITION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. POST HOC ANALYSIS FROM CONSUL, A LONGITUDINAL MULTI-CENTER RCT COHORT OF R-AXSPA-PATIENTS WITH A HIGH RISK OF STRUCTURAL PROGRESSION INITIATING TREATMENT WITH TNF-INHIBITOR
39. OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY
40. POS0043 COMPLEMENT IN RADIOGRAPHIC AXSPA – BIOMARKERS OF RADIOGRAPHIC PROGRESSION? POST HOC ANALYSIS FROM CONSUL, A LONGITUDINAL MULTI-CENTER RANDOMIZED CONTROLLED TRIAL COHORT OF AXSPA-PATIENTS WITH A HIGH RISK OF STRUCTURAL PROGRESSION INITIATING TREATMENT WITH TNF-I
41. POS0692 CAN THE ASSESSMENT OF DIAGNOSTIC CONFIDENCE BE USED AS A PARAMETER FOR IMAGE READER’S PERFORMANCE IN AXIAL SPONDYLOARTHRITIS? FIRST RESULTS OF THE DAMACT STUDY
42. POS0896 ANALYSIS OF THE PERFORMANCE OF AN ARTIFICIAL INTELLIGENCE ALGORITHM FOR THE DETECTION OF RADIOGRAPHIC SACROILIITIS IN AN INDEPENDENT COHORT OF AXSPA PATIENTS INCLUDING BOTH NR-AXSPA AND R-AXSPA
43. POS0298 THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS). RESULTS FROM THE PERSPECTIVE OF 5,557 PATIENTS FROM 27 COUNTRIES AROUND THE WORLD
44. AB0938 SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES
45. OP0055 ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS
46. POS0882 SCREENING/REFERRAL STRATEGIES FOR THE EARLY RECOGNITION OF PSA AMONG PATIENTS WITH PSORIASIS: RESULTS OF A GRAPPA SURVEY
47. OP0061 DEVELOPMENT OF EXTRA-MUSCULOSKELETAL MANIFESTATIONS IN UPADACITINIB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS, OR NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
48. Amélioration des signes et symptômes chez des patients atteints de spondyloarthrite axiale radiographique traités par bimékizumab : résultats à 24 semaines d’une étude de phase III, multicentrique, randomisée et contrôlée par placebo
49. Efficacité d’upadacitinib chez des patients atteints de spondyloarthrite axiale non radiographique en fonction des signes objectifs d’inflammation à l’inclusion
50. Profil de tolérance de l’ixékizumab dans le traitement du rhumatisme psoriasique et de la spondyloarthrite axiale jusqu’à 3 ans : mise à jour d’une analyse intégrée de tolérance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.